Background: Although the spine is the most common site of bone metastasis and the third most common site for metastatic disease following the lung and the liver, benign vertebral fracture due to osteopenia occurs in one third of cancer patients making it essential to determine whether the cause of vertebral collapse is benign or malignant. Objective: To detect and differentiate benign from malignant vertebral marrow lesions with the use of Diffusion weighted MRI and chemical shift in order to optimize the protocol needed for the accurate diagnosis. Materials and methods: In our study, we interpreted and analyzed the imaging data of 30 patients with suspected vertebral marrow lesion. They performed the routine MRI sequences of the spine (T1 , T 2, STIR, T 1 fat sat post-contrast enhancement) as well as the two non-routine sequences (DWI & in/opposed phase). We used the biopsy results or results of clinical and radiologic followup for at least 6 months, as the gold standard to classify the vertebral marrow infiltrative lesions as benign or malignant. Results: Statistical analysis of the collected results was performed using DWI with its quantitative best cutoff ADC value being 0.67 Â 10 À3 mm 2 /s and chemical shift imaging with its quantitative best cutoff SIR being 0.94 showed their diagnostic value in discrimination between benign and malignant lesions with overall 94% sensitivity, 79% specificity, 87% accuracy for ADC value and 94% sensitivity, 71% specificity, 83% accuracy for SIR. Conclusion: The addition of the two evolving MRI sequences (DWI and CSI) to the routine MRI protocol of cancer patients who examine the spine as part of their metastatic work-up promises to be an effective implement for characterization of vertebral marrow lesions being benign versus malignant.
Introduction
Vertebral marrow lesions in patients with known primary malignancy are a common clinical problem, particularly in elderly patients. In spite of osteoporosis being the commonest cause at this age, the spine also is a common site of metastases, with about 39% of all bone metastases occurring in the spine. Such metastases may result in a pathologic fracture (1) .
Differentiation of different vertebral marrow lesions whether pathologic from benign ones, definitely affects clinical staging, treatment strategy and prognosis in patients with known malignancies. Although conventional magnetic resonance (MR) imaging represents a sensitive method in the assessment of bone marrow, sometimes it lacks specificity (2) .
New techniques were tried for distinguishing between malignant and benign bone marrow with varying success. These included chemical shift imaging and diffusion-weighted MR imaging allowing for increased conspicuity of lesions. In equivocal findings of bone marrow lesions gadolinium enhanced study may be done. Although this increases the length and expense of the MR examination, it is not clear whether it improves diagnosis (2) .
The aim of our study was to evaluate the diagnostic accuracy of in-phase/opposed-phase quantitative chemical shift imaging of the spine and to determine the cutoff value between benign and malignant vertebral marrow lesions using diffusion weighted MRI imaging with quantitative ADC value, especially in patients with known primary malignant neoplasms.
Materials and methods

Subjects
This study included 30 patients, who were examined between June 2013 and January 2015, at MRI Unit of a University Hospital. Most of them were referred with a history of known primary malignancy and clinically suspected vertebral metastases. The rest of these patients were referred with back pain. Inclusion criteria were as follows: no age or sex predilection, any patient with primary neoplasm and suspected vertebral marrow lesion. Exclusion criteria were as follows: Patients who had not underwent a histopathological examination or 6 month follow-up (gold standard) and Patients known to have contraindications for MRI e.g. an implanted magnetic device, pacemakers and severe renal insufficiency with glomerular filtration rate <30 ml/min and serum creatinine >2.0 mg/dl as regards contrast injection. Our study population was presented to us either with back pain and/or with a neurological deficit after no or minimal trauma (e.g., falling from a standing height).
Those with known primary tumors were 23 patients of the 30 s: Lymphoma (n = 1), carcinoma of breast (n = 5), leukemia (n = 1), sarcoma (n = 5), carcinoma of prostate (n = 1), cervical chordoma (n = 1), thyroid carcinoma (n = 1), renal cell carcinoma (n = 1), hepatocellular carcinoma (n = 3) and bronchogenic carcinoma (n = 4).
All cases underwent conventional MRI (T1, T2, and STIR), DWI and chemical shift sequences. Twenty-four out of 30 patients received intravenously 0.1 mmol/kg of Gadolinium-DTPA as part of the routine protocol of oncology patient at our MRI unit. Two out of 30 patients did not receive intra-venous contrast because of severe renal insufficiency. The rest four patients refused to receive contrast.
Acquisition and processing of MRI
MR imaging of the spine was performed to 30 patients and it included examination of the cervical spine (n = 2), dorsal spine (n = 4) and lumbosacral region (n = 18); 1 patient had undergone cervicodorsal study, and 5 patients dorsolumbar study.
All examinations were performed on a 1.5 MR scanner (Achieva; Philips Medical Systems, Bothell, WA, USA) using a spine radio-frequency surface array coil.
Patients with known primary malignancy received gadolinium as part of the routine protocol of cancer patient at our MRI unit which consists of the following routine sequences: Unenhanced sagittal and axial T1-weighted fast spin-echo sequence, a sagittal and axial T2-weighted fast spin-echo sequence, a sagittal T2-weighted STIR sequence and a contrast enhanced sagittal and axial T1-weighted sequence with fat suppression.
In this study 2 non-routine sequences of sagittal diffusionweighted imaging and chemical shift (in/opposed phase) sequences were added to all patients.
Scanning protocol
Sagittal T1-weighted turbo spin echo images were acquired (TR/TE, 424/9; number of slices, 12; slice thickness, 4 mm; gap, 0.4 mm; flip angle, 80_; FOV, 300 mm 2 ). The total imaging time was 1:54 min. Axial T1-weighted turbo spin echo images were done (TR/ TE, 575/10; number of slices, 25; slice thickness, 5 mm; gap, 0.5 mm; flip angle, 80_; FOV, 200 mm 2 ). The total scan duration was 1:46 min. Sagittal T2-weighted turbo spin echo images were performed (TR/TE, 2578/100; number of slices, 12; slice thickness, 4 mm; gap, 0.4 mm; flip angle, 90_; FOV, 300 mm 2 ). The total imaging time was 1:51 min.
Axial T2-weighted turbo spin echo images were performed (TR/TE, 3000/100; number of slices, 25; slice thickness, 5 mm; gap, 0.5 mm; flip angle, 90_; FOV, 200 mm 2 ). The total imaging time was 1:06 min.
Sagittal T2-weighted STIR images were acquired (TR/TE, 3761/80; number of slices, 12; slice thickness, 3.8 mm; gap, 1.2 mm; flip angle, 90_; FOV, 300 mm 2 ). The total imaging duration was 2:08 min.
In addition to the routine sequences, sagittal in-phase (TR/ TE, 10/4.6; number of slices, 12; slice thickness, 4 mm; gap, 1 mm; flip angle, 15_; FOV, 300 mm 2 and the total imaging duration was 14.1 s) and opposed-phase gradient recalledecho sequences (TR/TE, 10/2. 3; number of slices, 12; slice thickness, 4 mm; gap, 1 mm; flip angle, 15_; FOV, 300 mm 2 and the total imaging duration was 13.6 s) were acquired.
DWI was performed with free breathing and inversion recovery single-shot spin-echo echo-planar sequences (TR/ TE, 9000/68; number of slices, 12; slice thickness, 5 mm; gap, 0 mm; flip angle, 90_; FOV, 300 mm 2 ). We applied 3 diffusion-sensitizing gradients with b-values of 0, 50 and 800 s/mm 2 . The total imaging time was 6:09 min.
After manual intravenous administration of 0.1 mmol/kg of gadolinium-DTPA, axial and sagittal T1-weighted fat suppressed sequences with the following parameters were applied: TR/TE, 574/10; number of slices, 12; slice thickness, 4 mm; gap, 0 mm; flip angle, 90°; FOV, 300 mm 2 . The total scan duration was 1:43 min for sagittal images and 2:26 min for axial scan.
The routine scan time was 7 min and 36 s, the DWI scan time was 6 min and 9 s and the chemical shift scan time was 27.7 s. So, DWI and CSI added to the routine scan time 6 min and 36.7 s.
Image analysis
All images were loaded to a workstation (HPZR 24 W; Philips Medical Systems). Bone marrow evaluation and image interpretation were performed by specialized radiologists. They interpreted both routine MRI sequences (T1-weighted, T2-weighted, STIR and gadolinium-enhanced T1-weighted fat-suppressed sequence) and non-routine sequences (DWI and in/opposed phase imaging).
Qualitative analysis
Bone marrow signal intensity was qualitatively analyzed by visually comparing its signal intensity with the signal intensity of the non-degenerated intervertebral disk, subcutaneous fat and muscle tissue depicted on T1-weighted images. For MRI interpretation, we used previously established diagnostic criteria for vertebral bone marrow evaluation to include the following: Malignant marrow lesions, whether multifocal or diffuse, were defined as those being isointense or hypo intense to muscle or intervertebral disk on T1-weighted images with corresponding hyper intensity on T2-weighted or STIR images and hyper intense on the DWI with a high b-value (b-value = 800), lack normal signal dropout on out-of-phase compared with in-phase images and show avid post-contrast enhancement.
On the other hand bone marrow lesion with signal intensity on T1-weighted images higher than disk and muscle, with no abnormal signal changes on STIR images, with a signal dropout on out-of-phase imaging compared with in-phase images, not hyper intense on high b value DWI and did not show post-contrast enhancement was classified as benign.
Quantitative analysis
Image post-processing was performed using a workstation (HP ZR 24 W; Philips Medical Systems). We quantitatively evaluated the bone marrow signal intensity by performing measurements in regions of interest (ROI). Hyper intense lesions on the DWI with a high b-value (b 800) which correspond to signal intensity changes on the T1-weighted spin-echo MR images were identified and the regions of interest were manually drawn. The ROI was lesion-size-dependent in localized discrete lesions, but in diffuse vertebral marrow lesions it was drawn as large as possible placed in the anterocentral aspect of vertebral body to avoid vertebral end plate degenerative changes and basivertebral vein plexus. These regions of interest varied between 5 and 15 mm in diameter. In each patient at least 3 ROIs were applied. The ROIs were copied into the computer memory and pasted onto registered ADC maps. ADC values were automatically calculated using the software provided by the MR scanner manufacturer (Diffusion Calculation: Philips Medical Systems) and the ADC quantitative parameter was expressed in square millimeters per second as mean ± SD.
The average ADC value of the three regions of interest of each patient was calculated and recorded.
As regards chemical shift imaging areas within the vertebral bodies that were of abnormal signal intensity on T1, T2 weighted and STIR sequences were identified on the in-phase and out-of-phase sequences. A region of interest (ROI) was applied to contain the abnormal area on the in-phase images and copied into the computer memory to be pasted onto the out-of-phase images. In case of multiple affected vertebrae only one representative lesion was used per patient.
In each affected vertebra 3 ROIs were applied to measure the signal intensity that was expressed as mean ± standard deviation (SD). The average signal intensity value of the three regions of interest was calculated and recorded for both inphase and out-phase sequences.
The signal intensity ratio (SIR) of the marrow mean signal intensity on the opposed-phase to the mean signal intensity on the in-phase images was calculated and recorded for each affected vertebra (benign and malignant) to quantitatively estimate the change that occurred in the signal intensity of abnormal marrow, with out-of-phase image.
The final diagnosis that was made on the basis of biopsy results or results of clinical and radiologic follow-+up for at least 6 months later, was used as the ''gold standard'' to classify the vertebral marrow infiltrative lesions as benign or malignant.
The malignant nature of the lesion was established by progressive deterioration of an affected vertebra or newly developed other spinal metastases at follow-up MR imaging, computed tomography, bone scintigraphy, or plain radiography. When the findings of the follow-up studies did not progress or if the abnormal signal intensity of the affected vertebra was resolved and reconstitution of normal marrow signal was monitored, the lesion was considered to be benign.
Statistical analysis
Data were analyzed using MedCalcÓ version 14 (MedCalcÓ Software bib, Ostend, Belgium) and the DAG Stat spreadsheet (Mackinnon, 2000) .
Normally distributed numerical variables were presented as mean (SD). Categorical variables were presented as number (%) and inter-group differences were compared using the Pearson chi-squared test or Fisher's exact test, when appropriate. Skewed numerical variables were presented as median (interquartile range) and between-group comparisons were done using the Mann-Whitney U test.
Receiver-operating characteristic (ROC) curve analysis was used to examine the value of the ADC or the SIR for discrimination between benign and malignant lesions. The DeLong method was used to compare the area under various ROC curves (AUC).
The diagnostic value of a restricted DWI pattern or no signal drop by CSI was examined by construction of two-by-two contingency tables with the ultimate classification of lesions into benign or malignant by biopsy or 6-month follow-up regarded as the gold standard for lesion classification. The following diagnostic indices were then calculated: sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio, correct classification rate, and misclassification rate.
Comparison of the sensitivities of restricted DWI pattern or no signal drop by CSI was examined by construction of a twoby-two contingency table for malignant lesions (positive group). Discordance between the two methods was then tested using the McNemar test. For comparison of the specificities of the two methods, a similar contingency table was constructed for benign lesions (negative group) and the McNemar test was applied to examine discordance between the two methods.
Inter-method agreement was assessed by calculation of the Cohen kappa statistic (j) and the prevalence-adjusted and bias-adjusted kappa (PABAK) coefficient.
Results
The studied population included 30 patients, 18 males (60%) and 12 females (40%). The mean age was 54 ± 13 years ranging from 25 to 80 years. Those with known primary malignant lesion were 23 patients (76.7%), while 7 patients (23.3%) had no known primary malignancy (Table 1 ) and (Fig. 1) .
The gold standard for lesion classification was either by biopsy or by 6 month follow-up. 16 (53.3%) patients were proved to be malignant and the other 14 (46.7%) were proved to be benign, in which 22 (73.3%) patients out of 30 showed restricted diffusion and 8 (26.7%) showed facilitated diffusion with median ADC value 0.6 (0.4-1.3) Â 10 À3 mm 2 /s. On the other hand 19 (63.3%) patients out of the 30 showed no signal drop on CSI and 11 (36.7%) showed signal drop with median SIR 1.13 (0.74-1.3).
15 (93.8%) out of the 16 patients proved to be malignant by the gold standard classification showed restricted diffusion with median ADC value 0.51 (0.37-0.60). Also, 15 (93.8%) of them showed no signal drop by CSI with median SIR 1.22 (1.10-1.31). The P-value is statistically significant (p < 0.05).
On the other hand 7 (50%) out of the 14 patients proved to be benign by the gold standard showed facilitated diffusion with median ADC value 1.30 (1.20-1.40) and 10 (71.4%) showed signal drop by CSI with median SIR 0.71 (0.59-1.30). The P-value is statistically significant ( Table 2 
The following table shows the diagnostic value of a restricted pattern by DWI for the discrimination between benign and malignant lesions with overall sensitivity of 0.94 (95% CI, 0.3-0.1), specificity of 0.50 (95% CI, 0.23-0.77) and accuracy of 0.73 (95% CI, 0.54-0.88) ( Table 3) .
On the other hand the following table shows the diagnostic value of no signal drop by CSI for the discrimination between benign and malignant lesions with overall sensitivity of 0.94 (95% CI, 0.70-1.0), specificity of 0.71 (95% CI, 0.42-0.92) and accuracy of 0.83 (95% CI, 0.65-0.94) ( Table 4 ). The results showed moderate agreement between DWI and CSI for the discrimination between benign and malignant lesions ( Table 5 ) (0.47 Cohen's Kappa and 0.53 prevalence and bias adjusted kappa).
14 patients out of the 16 proved to be malignant by the gold standard showed concordance results i.e. restricted diffusion on DWI with no Signal drop by CSI, while 6 patients out of the 14 proved to benign by the gold standard showed concordance results i.e. facilitated diffusion on DWI and signal drop on CSI (Table 6) .
Also, the results according to ROC curve for the discrimination between benign and malignant lesions (Table 7) using the ADC value showed that the best cutoff criterion is ADC of 60.67 (J-index, 0.72) with area under the ROC curve (AUC) 0.82, and this means that 60.67 indicates malignant result while >0.67 was defined as benign results with a sensi-tivity of 94%, specificity of 79% and accuracy of 87% (see Figs. [6] [7] [8] .
While the ROC curve for the discrimination between benign and malignant lesions (Table 8 ) using the SIR showed that the best cutoff criterion is SIR of >0.94 (J-index, 0.65) with area under the ROC curve (AUC) 0.75, this means that >0.94 indicates malignant result while <0.94 was defined as benign results with a sensitivity of 94%, specificity of 71% and accuracy of 83%.
The following table and figure show that the difference between the AUC of the ROC for the discrimination between benign and malignant lesions using the ADC value or the SIR is of p-value 0.662 which is statistically non-significant ( Table 9 ).
The results revealed that 13 patients out of the 16 proved to be malignant by the gold standard showed ADC value 60.67 & SIR >0.94 i.e. concordance results. And 7 patients out of 14 patients proved to be benign showed ADC value >0.67 & SIR <0.94 i.e. concordance results (Table 10) . The results showed moderate agreement between an ADC value 60.67 and a SIR >0.94 for the discrimination between benign and malignant lesions (0.39 Cohen's Kappa and 0.40 prevalence and bias adjusted kappa) (Table 11 ).
Discussion
MR imaging using conventional T1 WI and T2 WI had proven to be helpful in differentiating between benign and malignant causes of vertebral collapse but confident diagnosis is not always possible. When assessing contrast enhanced MRI, benign vertebral fractures may also enhance after intravenous administration of contrast media due to a breach in blood tissue. Dynamic contrast enhancement has been evaluated in the characterization of lesions in the brain, liver, breast, pelvis, etc., but this has not been evaluated in the spine (3) .
An often encountered diagnostic dilemma in the MRI interpretation is the difficulty in differentiating diffuse marrow infiltrative lesions from the highly variable appearance of normal hyper cellular hematopoietic red marrow (4). In a study done by Zhao et al. (5) who found that T1-weighted MRI accurately depicted and characterized the malignant multifocal metastatic deposits as well as focal and diffuse red marrow that exhibited signal intensity higher than adjacent muscle, but in our study 2 patients had profound red marrow reconversion ( Fig. 9 ) and 6 patients had advanced osteoporosis (Fig. 10) ; it was difficult to detect malignancy based on T1-weighted image alone. This came in agreement with Zidan and Elgahzaly (6).
Griffith et al. (7) reported that on T1-weighted images, osteoporosis can have a heterogeneous appearance because of decreased cellular marrow components and increased fat content. Also, hematopoietic marrow hyperplasia, diffuse (9) concluded that addition of T1-weighted contrast-enhanced MR imaging does not alter the diagnosis of bone marrow abnormalities, and for most cases, they recommend performing only the STIR sequence. Accordingly, in our study we applied the two newly developed noncontrast-based DWI and opposed phase chemical shift MR techniques (non-routine sequences) on all cases.
Over the last decade, DWI MR imaging of the vertebral body has proved its value and has been successfully implemented for the differentiation of benign and malignant Fig. 8 Comparison of the receiver-operating characteristic (ROC) curves for the discrimination between benign and malignant lesions using the ADC value or the SIR. fracture edema (due to tumor infiltration). DWI MRI provides unique tissue characterization that is complementary to that provided by conventional MR imaging and is sensitive to microstructural changes. The reduced mobility of water in pathologic fracture is the result of tumor cell accumulation and subsequent reduction in the interstitial spaces that results in high signal intensity compared with normal bone marrow. On the other hand, the increased mobility of water attributed to an increase in the interstitial space in relation to edema or hemorrhage in benign fractures results in low signal intensity in benign osteoporotic and traumatic fractures (3) .
In our study we found that visual assessment of high-signal intensity on high b-value (800) was not specific for malignancy because inflammation and hyperactive hematopoietic marrow can result in a similar diffusion restriction, and this came in agreement with Koh et al. (10) and Ballon et al. (11) . On the other hand the quantitative assessment by measuring the ADC value was able to distinguish benign from malignant high signal intensity on DWI ( Figs. 11 and 9 ). This was in agreement with Zidan and Elghazaly (6) and Padhani et al. (12) who highlighted the necessity of correlating high b-value DW images with corresponding ADC values to prevent misinterpretation due to T2 shine-through. Our observations were supported by Hillengass et al. (13) who showed that normal yellow marrow had the lowest ADC value and the infiltrated neoplastic marrow as well as hyper cellular red marrow had higher ADC value ( Fig. 9) , with the infective/inflammatory bone marrow lesion had the highest ADC value (Fig. 11) .
Thus, it was concluded that signal intensity and ADC value difference between yellow marrow and malignant marrow were not overlapping, but the signal intensity difference between malignant and inflammatory/infective lesion was overlapping although the ADC value difference between the two entities was statistically significant with p value < 0.05. This came in agreement with Padhani et al. (12) and Zidan and Elghazaly (6) .
The diagnostic problem of narrow signal intensity difference between hypercellular red marrow and malignant infiltration was almost solved by the addition of in/out of-phase chemical shift sequence to the MRI protocol.
Using ROC analysis, we identified an ADC cutoff value of 0.67 between benign and malignant vertebral marrow lesions, which is lower than that reported by Wonglaksonapimon et al. (14) , namely 0.89, with sensitivity, specificity and accuracy were 86%, 91% and 90% respectively. In our study an ADC cutoff value of 0.67 resulted in 94% sensitivity, 79% specificity and 87% accuracy in the discrimination between benign and malignant vertebral marrow lesions. These results were in concordance with Sung et al. (15) who reported 100% sensitivity and 97% specificity.
Chemical shift imaging takes advantage of the small differences in precession frequency between fat and water protons to determine the presence of microscopic fat and water within the same imaging voxel. If a given voxel contains both fat and water, drop of signal on out-of-phase images will be noted (16) .
On the other hand, lesions composed of virtually 100% fat will not show a drop of signal on out-of-phase sequence, and this was in concordance with our findings where some hemangioma, fat island, Modic type 2 vertebral endplate marrow changes and radiotherapy induced profound fatty arrow did not exhibit signal dropout (Fig. 12 ). Red marrow shows normal signal dropout on out-of-phase images because of the presence of both fat and water cells, but most neoplasms completely replace or displace fat in the marrow space; thus, the neoplastic area will lack normal signal dropout on out-of-phase images (16) . And this was consistent with our findings and in agreement with Zidan et al. (17) . Roberts et al. (18) suggested out-of-phase sequence to best assess for marrow replacement by tumor. In our study the 2 cases with hypercellular red marrow showed a drop in signal intensity on out-of-phase images, but no drop in signal intensity was noted in malignant marrow lesions, and these results were concordant with Moulopoulos et al. (19) .
In our cases the addition of chemical shift sequence improved the MRI diagnostic performance in discriminating between benign and malignant marrow lesions.
We totally agreed with Zajack et al. (2) who noted that we should not depend on visual conspicuity, as in our study we found that the inflammatory/infective lesions showed no signal drop in out of phase as regards visual assessment while quantitatively they were in concordance with benign lesions.
We expressed the findings of our results in the form of a ratio, which compared the signal intensity in the abnormal bone marrow on the out-of-phase and in-phase images. This signal intensity ratio was calculated as the mean signal intensity on out-of-phase images divided by the mean signal intensity on the in-phase images. By using this formula which was also used in other studies, we calculated in our study a mean signal intensity ratio of 1.22 (range 1.10-1.31) for the neoplastic group and 0.71 (range 0.59-1.30) for the benign group (P < 0.05), and these results were in concordance with Ogura et al. (20) .
Using ROC analysis, we identified in our study a SIR cutoff value of 0.94 between benign and malignant vertebral compression fractures, which is higher than that reported by Erly et al. (21) namely 0.8, but less than the cutoff value of one reported by Ogura et al. (20) . In our study a SIR cutoff value of 0.94 resulted in 93% sensitivity, 72% specificity and 88% accuracy in the discrimination between benign and malignant vertebral compression fractures. These results were in concordance with Zidan et al. (17) who reported 93% sensitivity and 82% specificity, and with Erly et al. (21) who reported 95% sensitivity and 89% specificity.
These results however, differ from the results of another study done by Geith et al. (22) in which 69.2% of all osteoporotic fractures showed a hyperintense signal on opposed phase images (false-positive). They did not find a significant difference in SI on the opposed-phase images of benign and malignant vertebral lesions, and were able to reach a sensitivity of only 50%, and a specificity of 88.5%. In an attempt to explain their results, they noted that this finding could be attributable to the fact that an equal amount of 50% fat and 50% water is not always present in benign lesions because of edema, resulting in more or less of a hyperintense signal on the opposed-phase images. Some overlap in the signal intensity ratio between the malignant and the benign marrow lesions, also occurred in our study, as benign lesions in 4 patients had a ratio greater than 0.94 and a single malignant lesion in one patient had a value less than 0.94.
The false positive results in CSI were seen in 4 patients, 2 of them had Pott's disease and 2 had pyogenic spondylodiscitis with massive bone marrow edema that did not show signal dropout on out-of-phase sequence due to abundant water; however, the edema did appear clearly on the T2WI and STIR sequences.
In our patient population 15 out of 16 malignant vertebral compressions did not show a signal dropout on out-of-phase images. This was in agreement with Swartz and Robert (23) who reported false negative pitfalls due to dense sclerotic or fat containing metastases.
Our results showed that the sensitivity, specificity and accuracy for diffusion weighted imaging were 94%, 92%, and 93% respectively, which were almost comparable to those calculated for chemical shift imaging, where sensitivity of 93%, specificity of 72% and accuracy of 93% were reported.
In conclusion, we suggest that quantitative diffusion weighted imaging and chemical shift MR imaging could be a valuable addition to standard MR imaging techniques and represent a rapid problem solving tool in differentiating benign from malignant vertebral marrow lesions, especially in patients with known primary malignancies. 
